Related Experiment Video

Updated: Apr 23, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K

PIK3CA in ovarian clear cell carcinoma

Gian Franco Zannoni1, Giuseppina Improta2, Filippo Fraggetta3

  • 1Department of Pathology, Catholic University of the Sacred Heart, Rome, Italy.

Human Pathology
|September 24, 2014
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Clear cell carcinomaMolecular analysisOvaryPIK3CA

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

14.8K

Related Experiment Videos

Last Updated: Apr 23, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

14.8K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K

Articles linked to this work by shared authors, journal, and citation graph.

Placental Histopathology and Adverse Perinatal Outcomes in ART Pregnancies: A Comparative Analysis of Homologous and Heterologous Techniques.

Diagnostics (Basel, Switzerland)·2026

Cervical Cytological Findings and Vaginal Microbiota Alterations During Pregnancy: A Retrospective Analysis.

Sage open pathology·2026

Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trial.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Fertility-sparing treatment in stage IA grade 2 endometrioid endometrial cancer: Outcomes of a standardized approach.

Gynecologic oncology·2026

p16(INK4a) immunohistochemical expression is a strong predictor of treatment response and survival in patients with locally advanced squamous cell vulvar cancer undergoing upfront chemoradiotherapy.

Journal of gynecologic oncology·2026

Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026

Histologic Patterns of Metastatic Lymph Nodes and Recurrence Patterns in Resected pN1-2 Lung Adenocarcinoma.

Human pathology·2026

Pathologist-Recommended Molecular Testing in Endometrial Cancer: A Single-Institution Experience Highlighting the Recognition of POLE-Mutated Carcinomas in Post-Menopausal and Advanced Stage Patients, Immunohistochemical Pitfalls, and Other Clinically Significant Findings.

Human pathology·2026

Thyroid Nodules of Uncertain Malignant Potential Non-Conforming to World Health Organization Diagnostic Criteria - Clinicopathologic and Molecular Characterization of 39 Cases.

Human pathology·2026

Neuroendocrine Cell Proliferation in Gastric and Gastroesophageal Carcinomas Following Neoadjuvant Therapy: Frequency and Association with Clinicopathological Parameters and Prognosis.

Human pathology·2026

Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic ductal adenocarcinoma.

Human pathology·2026

Duct Quest: An international survey of genitourinary and community pathologists reveals diagnostic uncertainties in separating atypical intraductal proliferation from high-grade prostatic intraepithelial neoplasia and intraductal carcinoma of the prostate.

Human pathology·2026

Ageing-associated regenerative failure in the lung: stem cell senescence and transitional cell persistence in idiopathic pulmonary fibrosis.

European respiratory review : an official journal of the European Respiratory Society·2026

WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancer.

Gastroenterology·2026

WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-mediated cytoskeletal Remodeling.

Gastroenterology·2026

Tumors exploit interclonal Hedgehog-Wnt crosstalk to drive tumor-promoting cell competition.

Developmental cell·2026

Synchronous collagenous and ulcerative colitis: A case report and review of the literature.

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia·2026

Construction of Human Breast Cancer Organoids and Comet Assay-Based Quantification of Doxorubicin-Induced DNA Damage.

Journal of visualized experiments : JoVE·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us